TetraLogic Pharmaceuticals Corporation (TLOG)

USD 0.0

(0.0%)

Annual Income Statements

(In USD)
Breakdown 2022 2021 2020 2019 2015 2014
Revenue - - - - - -
Cost of Revenue - - - - 187.99 Thousand -
Gross Profit - - - - -187.99 Thousand -
Operating Expenses - - - - 38.5 Million 31.21 Million
Selling, General and Administrative Expenses - - - - 11.09 Million 10.92 Million
Research and Development Expenses - - - - 27.4 Million 20.28 Million
Other Expenses - - - - - -
Cost and Expenses - - - - 38.5 Million 31.21 Million
Operating Income - - - - -44.99 Million -33.78 Million
Interest Expense - - - - 6.38 Million 3.35 Million
Income Tax Expense - - - - 6.38 Million 3.35 Million
Earnings before Tax - - - - -49.72 Million -35.95 Million
Net Income - - - - -56.1 Million -39.31 Million
Earnings Per Share Basic - - - - -2.37 -1.76
Earnings Per Share Diluted - - - - -2.36 -1.76
Weighted Average Shares Outstanding - - - - 23.69 Million 22.29 Million
Weighted Average Shares Outstanding (Diluted) - - - - 23.73 Million 22.35 Million
Gross Margin - - - - - -
EBIT Margin - - - - - -
Profit Margin - - - - - -
EBITDA - - - - -43.15 Million -32.47 Million
Earnings Before Tax Margin - - - - - -

Income Statement Charts